Turtle Beach Corporation (NASDAQ: HEAR) is a leading gaming accessories brand. The Company’s namesake Turtle Beach brand is known for designing best-selling gaming headsets, top-rated game controllers, award-winning PC gaming peripherals, and groundbreaking gaming simulation accessories. Turtle Beach Corporation (NASDAQ: HEAR) Market Cap: $331.67M; Current Share Price:...
Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) operates at the intersection of metals recovery, reuse, recycling, and manufacturing. As a vertically integrated organization, Schnitzer offers a range of products and services to meet the global demand for recycled ferrous and nonferrous metal. Schnitzer Steel Industries, Inc. (NASDAQ:...
DocGo Inc. (NASDAQ: DCGO), a leading provider of last-mile mobile health services, is disrupting the traditional four-wall healthcare system by providing high-quality, highly affordable care to patients where and when needed. With Mobile Health, DocGo empowers the potential of telehealth by facilitating healthcare treatment, in...
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a biopharmaceutical company developing novel treatments for dermatological diseases, announced the acceptance of the New Drug Submission (NDS) for roflumilast cream 0.3% (ARQ-151) for the treatment of plaque psoriasis in adults and adolescents, filed by Arcutis Canada Inc., a subsidiary of...
Collaboration Agreement with Sanofi IGM Biosciences, Inc. (NASDAQ: IGMS), a biotechnology company leveraging its expertise in Immunoglobulin M (IgM) antibodies, announced an exclusive worldwide collaboration agreement with Sanofi (NASDAQ: SNY). The agreement is for developing and commercializing IgM antibody agonists against six initial targets, three in...
Allakos, Inc. (NASDAQ: ALLK), a clinical-stage biopharmaceutical company developing therapeutic monoclonal antibodies for treatment of inflammatory, and proliferative diseases, faced a setback with disappointing results from a crucial phase 3 trial named Enigma 2 and phase 2/3 Kryptos trial. The studies were evaluating the Company’s...
Technology Industry has been focused on leaving the COVID-19 pandemic behind, and marching ahead with its innovations and breakthroughs, be it critical security systems, innovative marketing solutions or cutting-edge data analytics and search technology. We look at some technology companies that are impervious to the scare...
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on creating novel therapeutics that use molecules to treat medical conditions with no approved cure. The Company’s lead product candidate is ZYESAMI™ (AVIPTADIL®) ZYESAMI™ (Aviptadil acetate), a synthetic Vasoactive Intestinal Peptide (VIP), which has...
